Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CMPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CMPS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Compass Pathways Plc

CMPS
Current price
2.35 USD -0.73 USD (-23.70%)
Last closed 4.63 USD
ISIN US20451W1018
Sector Healthcare
Industry Medical Care Facilities
Exchange NASDAQ
Capitalization 449 096 672 USD
Yield for 12 month -62.64 %
1Y
3Y
5Y
10Y
15Y
CMPS
21.11.2021 - 28.11.2021

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.82 USD

P/E ratio

Dividend Yield

Financials CMPS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CMPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-242 938 USD

Current Quarter

Last Quarter

EBITDA -162 595 008 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -32.40 %
PEG Ratio
Return On Equity TTM -60.62 %
Wall Street Target Price 16.82 USD
Revenue TTM
Book Value 2.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.99 USD
Diluted Eps TTM -1.99 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CMPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.51
Price Book MRQ 2.14

Technical indicators CMPS

For 52 weeks

2.49 USD 8.54 USD
50 Day MA 3.98 USD
Shares Short Prior Month 5 100 995
200 Day MA 4.57 USD
Short Ratio 4.66
Shares Short 4 835 367
Short Percent 5.27 %